NCT02263885View on ClinicalTrials.gov

ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 15, 2019

Study Completion Date

July 26, 2019

Conditions
Parkinson's Disease
Interventions
DEVICE

ExAblate Transcranial System

Transcranial MRgFUS

Trial Locations (5)

21201

University of Maryland Medical System, Baltimore

22908

University of Virginia, Charlottesville

43210

The Ohio State Wexner Medical Center, Columbus

94305

Stanford University Medical Center, Stanford

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT02263885 - ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter